A detailed history of Fifth Third Bancorp transactions in Legend Biotech Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 276 shares of LEGN stock, worth $10,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares
276
Previous 266 3.76%
Holding current value
$10,971
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$43.55 - $59.88 $435 - $598
10 Added 3.76%
276 $13,000
Q2 2024

Jul 22, 2024

BUY
$39.5 - $57.22 $1,935 - $2,803
49 Added 22.58%
266 $11,000
Q1 2024

Apr 23, 2024

BUY
$55.06 - $69.99 $1,321 - $1,679
24 Added 12.44%
217 $12,000
Q4 2023

Jan 19, 2024

BUY
$57.25 - $69.74 $2,748 - $3,347
48 Added 33.1%
193 $11,000
Q3 2023

Oct 31, 2023

BUY
$63.16 - $76.5 $4,484 - $5,431
71 Added 95.95%
145 $9,000
Q2 2023

Jul 25, 2023

BUY
$46.28 - $75.01 $3,424 - $5,550
74 New
74 $5,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.65B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.